Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2011

Open Access 01-12-2011 | Case report

Intramuscular myxoma associated with an increased carbohydrate antigen 19.9 level in a woman: a case report

Authors: Dimitrios Theodorou, Eleftheria S Kleidi, Georgia I Doulami, Panagiotis G Drimousis, Andreas Larentzakis, Kostas Toutouzas, Stylianos Katsaragakis

Published in: Journal of Medical Case Reports | Issue 1/2011

Login to get access

Abstract

Introduction

Intramuscular myxoma is a rare benign soft tissue tumor. The lack of specific symptoms and widely used laboratory tests makes the diagnosis quite difficult. We present a case of an Intramuscular myxoma associated with an increased carbohydrate antigen 19.9 level. To the best of our knowledge, there have not been any reported cases of an association of Intramuscular myxoma with tumor markers in the literature.

Case presentation

A 45-year-old Caucasian woman presented to our department for resection of a mass in her left groin area, discovered incidentally on a triplex ultrasonography of her lower extremities. The diagnosis of Intramuscular myxoma was confirmed on histopathology after the complete surgical excision of the tumor. On laboratory examination, the serum level of carbohydrate antigen 19.9 was found to be elevated, but it returned to normal six months after resection of the mass.

Conclusion

Carbohydrate antigen 19.9 is a tumor marker that increases in a variety of malignant and benign conditions. After the exclusion of all other possible reasons for carbohydrate antigen 19.9 elevation, we assumed a possible connection of carbohydrate antigen 19.9 elevation and Intramuscular myxoma, an issue that requires needs further investigation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Vilanova J, Woertler K, Narváez J, Barceló J, Martínez S, Villalón M, Miró J: Soft-tissue tumors update: MR imaging features according to the WHO classification. Eur Radiol. 2007, 17 (1): 125-138. 10.1007/s00330-005-0130-0.CrossRefPubMed Vilanova J, Woertler K, Narváez J, Barceló J, Martínez S, Villalón M, Miró J: Soft-tissue tumors update: MR imaging features according to the WHO classification. Eur Radiol. 2007, 17 (1): 125-138. 10.1007/s00330-005-0130-0.CrossRefPubMed
2.
go back to reference Wakely P, Bos G, Mayerson J: The cytopathology of soft tissue myxomas, ganglia, juxta-articular myxoid lesions, and Intramuscular myxoma. Am J Clin Pathol. 2005, 123 (6): 858-865. 10.1309/39YX94KXT0T2CNUX.CrossRef Wakely P, Bos G, Mayerson J: The cytopathology of soft tissue myxomas, ganglia, juxta-articular myxoid lesions, and Intramuscular myxoma. Am J Clin Pathol. 2005, 123 (6): 858-865. 10.1309/39YX94KXT0T2CNUX.CrossRef
3.
go back to reference Hiroyuki O, Masato F, Toshiki T, Kaoru O: Intramuscular myxoma of scalene muscle: a case report. Auris Nasus Larynx. 2004, 31 (3): 319-322. 10.1016/j.anl.2004.03.009.CrossRef Hiroyuki O, Masato F, Toshiki T, Kaoru O: Intramuscular myxoma of scalene muscle: a case report. Auris Nasus Larynx. 2004, 31 (3): 319-322. 10.1016/j.anl.2004.03.009.CrossRef
4.
go back to reference Murphey M, McRae G, Fanburg-Smith J, Temple T, Levine A, Aboulafia A: Imaging of soft-tissue myxoma with emphasis on CT and MR and comparison of radiologic and pathologic findings. Radiology. 2002, 225 (1): 215-224. 10.1148/radiol.2251011627.CrossRefPubMed Murphey M, McRae G, Fanburg-Smith J, Temple T, Levine A, Aboulafia A: Imaging of soft-tissue myxoma with emphasis on CT and MR and comparison of radiologic and pathologic findings. Radiology. 2002, 225 (1): 215-224. 10.1148/radiol.2251011627.CrossRefPubMed
5.
go back to reference Nielsen GP, O'Connell JX, Rosenberg AE: Intramuscular myxoma: a clinicopathologic study of 51 cases with emphasis on hypercellular and hypervascular variants. Am J Surg Pathol. 1998, 22 (10): 1222-1227. 10.1097/00000478-199810000-00007.CrossRefPubMed Nielsen GP, O'Connell JX, Rosenberg AE: Intramuscular myxoma: a clinicopathologic study of 51 cases with emphasis on hypercellular and hypervascular variants. Am J Surg Pathol. 1998, 22 (10): 1222-1227. 10.1097/00000478-199810000-00007.CrossRefPubMed
6.
go back to reference Bancroft L, Kransdorf M, Menke D, O'Connor M, Foster W: Intramuscular myxoma characteristic MR imaging features. AJR. 2002, 178 (5): 1255-1259.CrossRefPubMed Bancroft L, Kransdorf M, Menke D, O'Connor M, Foster W: Intramuscular myxoma characteristic MR imaging features. AJR. 2002, 178 (5): 1255-1259.CrossRefPubMed
7.
go back to reference Zoccali C, Teori G, Principe U, Erba F: Mazabraud's syndrome: a new case and review of the literature. Int Orthop. 2009, 33 (3): 605-610. 10.1007/s00264-007-0483-x.CrossRefPubMed Zoccali C, Teori G, Principe U, Erba F: Mazabraud's syndrome: a new case and review of the literature. Int Orthop. 2009, 33 (3): 605-610. 10.1007/s00264-007-0483-x.CrossRefPubMed
8.
go back to reference Delaney D, Diss TC, Presneau N, Hing S, Berisha F, Idowu BD, O'Donnell P, Skinner JA, Tirabosco R, Flanagan AM: GNAS1 mutations occur more commonly than previously thought in intramuscular myxoma. Mod Pathol. 2009, 22 (5): 718-724. 10.1038/modpathol.2009.32.CrossRefPubMed Delaney D, Diss TC, Presneau N, Hing S, Berisha F, Idowu BD, O'Donnell P, Skinner JA, Tirabosco R, Flanagan AM: GNAS1 mutations occur more commonly than previously thought in intramuscular myxoma. Mod Pathol. 2009, 22 (5): 718-724. 10.1038/modpathol.2009.32.CrossRefPubMed
9.
go back to reference Graadt van Roggen JF, Hogendoorn PCW, Fletcher CDM: Myxoid tumours of soft tissue. Histopathology. 1999, 35 (4): 291-312. 10.1046/j.1365-2559.1999.00835.x.CrossRefPubMed Graadt van Roggen JF, Hogendoorn PCW, Fletcher CDM: Myxoid tumours of soft tissue. Histopathology. 1999, 35 (4): 291-312. 10.1046/j.1365-2559.1999.00835.x.CrossRefPubMed
10.
go back to reference Bekaii-Saab TS, Cowgill SM, Burak WE, Melvin WS, Ellison EC, Muscarella P: Diagnostic accuracy of serum CA19.9 in predicting malignancy in patients undergoing pancreatic resection. Proc ASCO. 2004, 22 (14S): 4210- Bekaii-Saab TS, Cowgill SM, Burak WE, Melvin WS, Ellison EC, Muscarella P: Diagnostic accuracy of serum CA19.9 in predicting malignancy in patients undergoing pancreatic resection. Proc ASCO. 2004, 22 (14S): 4210-
11.
go back to reference Ventrucci M, Pozzato P, Cipolla A, Uomo G: Persistent elevation of serum CA 19.9 with no evidence of malignant disease. Dig Liver Dis. 2009, 41 (5): 357-363. 10.1016/j.dld.2008.04.002.CrossRefPubMed Ventrucci M, Pozzato P, Cipolla A, Uomo G: Persistent elevation of serum CA 19.9 with no evidence of malignant disease. Dig Liver Dis. 2009, 41 (5): 357-363. 10.1016/j.dld.2008.04.002.CrossRefPubMed
Metadata
Title
Intramuscular myxoma associated with an increased carbohydrate antigen 19.9 level in a woman: a case report
Authors
Dimitrios Theodorou
Eleftheria S Kleidi
Georgia I Doulami
Panagiotis G Drimousis
Andreas Larentzakis
Kostas Toutouzas
Stylianos Katsaragakis
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2011
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/1752-1947-5-184

Other articles of this Issue 1/2011

Journal of Medical Case Reports 1/2011 Go to the issue